CASP3 and cholangiocarcinoma: The expression of cleaved Caspase-3 and cleaved PARP1 significantly increased after silibinin treatment, which means that silibinin induced cholangiocarcinoma cell death by activating apoptosis pathways (Figures 2D,E).